VIP-SSM (University of Illinois/University of Illinois at Urbana-Champaign)

N/A

Report date: 2025/01/26 16:34:33

Base Information

Drug NameVIP-SSM (University of Illinois/University of Illinois at Urbana-Champaign)
Drug Alias Namevasoactive intestinal peptide-stabilized phospholipid nanomicelles (University of Illinois/University of Illinois at URBANA-CHAMPAIGN)VIP-SSM (University of Illinois)vasoactive intestinal peptide-stabilized phospholipid nanomicelles (University of Illinois)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsVasoactive intestinal peptide receptor agonists
TargetsVasoactive intestinal peptide receptorBeta amyloid A4 protein
Therapy Area/IndicationsWounds and InjuriesInflammationEye Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Illinois
Inactive CompaniesUniversity Of Illinois At Urbana–Champaign
Active IndicationsColitis
Inactive IndicationsWounds and InjuriesInflammationEye Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A